High Finance with Peter Su ft. Elliot Lane: SVP Benzinga

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Latest News

New Zealand Approves Psilocybin for Medicinal Use

HCN News Team2025-06-23T08:55:25-08:00June 23rd, 2025|

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

Psyence Group Inc. Announces C$600,000 Private Share Offering

HCN News Team2025-06-23T08:54:06-08:00June 23rd, 2025|

LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...

Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban

HCN News Team2025-06-23T08:53:58-08:00June 23rd, 2025|

LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, ...